Shizue Spielberg and her husband, Harold, started funding MDS research through AA&MDSIF in 1998 after he was diagnosed with MDS. In 1999, following his death, Mrs. Spielberg decided to honor him by establishing the Harold Spielberg MDS Research Fund. Her goal is for us to better understand how to treat and cure MDS. This fund has been supporting research grants regularly thanks to the generosity of Mrs. Spielberg and her company.
AAMDSIF Harold Spielberg Research Fund
Grant Recipient(s)
| Research Title | Grant Year | |
|---|---|---|
| Simone Feurstein, MD | Autoimmunity and immunodeficiency in young adults with myelodysplastic syndrome | 2023 |
| David Beck, MD, PhD | Advanced genomic and molecular investigation of acquired bone marrow failure syndromes | 2022 |
| Salima Benbarche, PhD | Developing synthetic introns for targeting spliceosomal mutant MDS | 2021 |
| Audrey Lasry, PhD | Single cell mapping of bone marrow microenvironment during MDS to AML transition | 2020 |
| Sydney Lu, MD, PhD | Therapeutic targeting of spliceosomal-mutant myelodysplastic syndromes with anti-cancer sulfonamides | 2018 |
| Coleman Lindsley, MD, PhD | Impact of telomere length and telomerase gene mutations on allogeneic stem cell transplantation outcomes in myelodysplastic syndromes | 2017 |
| Britta Will, PhD | Therapeutic targeting of aberrant stem cells in MDS | 2015 |
| Zhe Yang, PhD | Structural insights into deregulated epigenetic mechanisms and DNA demethylation in MDS | 2012 |
| Mridul Mukherji, DPhil | Rescue of TET2 Mutations from MDS Patients | 2011 |
| Muneyoshi Futami, MD, PhD | Molecular basis for disordered myeloid growth in Monosomy 7 | 2010 |
| Archibald S. Perkins, MD, PhD | Development of Targeted Therapies for 3q26-positive MDS | 2009 |